Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-1906
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2019 - 2022
Massachusetts General HospitalResidency, Internal Medicine, 2016 - 2019
Stanford University School of MedicineClass of 2016
Certifications & Licensure
MA State Medical License 2019 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsImpact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL.Ibrahim Aldoss, Gregory W Roloff, Rawan Faramand, Noam E Kopmar, Chenyu Lin
Blood Advances. 2024-12-10 - Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort.Jacqueline N Poston, Cassandra Bryan, Annette von Drygalski, Kadhim Al Banaa, Jenny Y Zhou
Blood Advances. 2024-11-26 - 1 citationsIntensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AML.Jan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, Yiwen Liu, Guillaume Berton
Blood Advances. 2024-09-24
Press Mentions
New Insights Emerge on Treatment Outcomes for Accelerated or Blast-Phase Myeloproliferative NeoplasmsOctober 4th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
